Researchers have discovered a blood protein that could help detect which children will experience ongoing concussion symptoms more than two weeks after an injury.
, found the protein was a potential biomarker for delayed recovery from concussion in children.
Of the four million children who experience a concussion each year, 25-30 per cent will have long-term symptoms and about half will never seek out medical care. Symptoms including headaches, difficulty remembering and sensitivity to light can last for months while mental health conditions can persist for several years.
"If the finding holds up in larger studies, the discovery could contribute to acute clinical management by providing clinicians with an acute marker to guide more timely and targeted treatments to children most likely to experience long-term problems," she said. "When I woke up, I couldn't see out of my eye and I was lying in a pool of my own blood. I felt dizzy, confused and everything became a blur."
Mackenzie's mum Karen Payne, who will never forget the image of her daughter lying unconscious on the court, said the latest MCRI research would come as a welcome to relief to families.
Infant's Health Sports Medicine Accident And Trauma Child Psychology Intelligence Child Development Brain Injury
United States Latest News, United States Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Researchers say blood test good at detecting colon cancer, not at finding polypsA WellSpan doctor looked into the test to see where it stacks up against colonoscopies.
Read more »
Adam Joseph donates blood for second time at Red Cross blood driveYou can also help save lives at the 6abc Philly Blood Drive on March 27, 2024, in Pennsylvania and New Jersey.
Read more »
LifeSouth Community Blood Centers Urgently Seek Blood DonationsLifeSouth Community Blood Centers urgently seek blood donations due to a current decline and said all blood types are needed. Donors will receive a $20 e-gift card, but double red cell and platelet donors will receive a $40 e-gift card plus a mini-physical.
Read more »
Jennifer Blood: Battle Diary #5 Preview: Blood's Last Stand?Well, well, well, looks like our dear Jennifer Blood has gone from being the puppet master to just another marionette tangled in her own strings.
Read more »
New study claims high blood pressure begins during childhoodResearchers now believe the seeds for the raised blood pressure can begin when we are children.
Read more »
FDA Approves Danicopan as Add-On Therapy for Hemolysis TreatmentThe US Food and Drug Administration has approved danicopan (Voydeya, AstraZeneca) as an add-on therapy to treat extravascular hemolysis in adults receiving ravulizumab orPNH is a rare blood disorder affecting 1-10 individuals per million. The condition, which eliminates red blood cells and leads to blood clots and impaired bone marrow function, can cause life-threateningRavulizumab and eculizumab, also both made by AstraZeneca, inhibit the destruction of red blood cells. However, 10%-20% of patients treated with the antibody infusions experience significant extravascular hemolysis, in which these surviving red blood cells are eliminated by the spleen and liver. Extravascular hemolysis can lead to ongoing anemia, which can lead patients to require blood transfusions. Danicopan, an investigational, first-in-class, oral complement factor D inhibitor, is designed to control intravascular hemolysis and prevent extravascular hemolysis
Read more »